Cambria Investment Management’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.1M Sell
935,059
-487,152
-34% -$4.17M 0.57% 29
2025
Q4
$8.69M Buy
+1,422,211
New +$8.49M 0.51% 61
2023
Q1
Sell
-89,648
Closed -$1.51M 296
2022
Q4
$1.51M Buy
89,648
+34,480
+63% +$569K 0.13% 141
2022
Q3
$644K Buy
55,168
+34,588
+168% +$494K 0.07% 166
2022
Q2
$324K Sell
20,580
-5,270
-20% -$88.5K 0.04% 188
2022
Q1
$400K Buy
25,850
+3,525
+16% +$44.5K 0.05% 165
2021
Q4
$189K Hold
22,325
0.03% 255
2021
Q3
$201K Hold
22,325
0.04% 230
2021
Q2
$222K Buy
22,325
+3,525
+19% +$29.8K 0.04% 199
2021
Q1
$134K Buy
+18,800
New +$132K 0.03% 213

Other funds holding PTEN

Cambria Investment Management's PTEN Position: Q1 2026 in Review

Cambria Investment Management reduced its Patterson-UTI (PTEN) stake by 34% in Q1 2026, selling an estimated $4.17M and leaving 935,059 shares worth $10.1M. The position accounts for 0.57% of the portfolio, ranked #29.

Cambria Investment Management first reported a position in PTEN in Q1 2021 and has held it in 10 quarters since. 410 funds tracked by Wall St. Rank hold PTEN as of Q1 2026.

  • Cambria Investment Management held 935,059 shares of Patterson-UTI worth $10.1M as of Q1 2026.
  • Cambria Investment Management sold 487,152 Patterson-UTI shares in Q1 2026, an estimated $4.17M.
  • Patterson-UTI made up 0.57% of Cambria Investment Management's portfolio in Q1 2026, its #29 holding.
  • Cambria Investment Management first reported a position in Patterson-UTI in Q1 2021 and has held it in 10 quarters since.
  • 410 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2026.

Based on Cambria Investment Management's 13F filing for Q1 2026, filed 15 May 2026.